Work

Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies

FWCI: 3.293
Cites: 55
Cited by: 82
Related to: 10